Mexico’s Magic Mushroom Tourism Industry

The term ‘cannabis tourism’ denotes a well-known concept. People travel to destinations where they can specifically take part in cannabis consumption activities. Cannabis is not the only drug that drives tourism though, as Mexico’s burgeoning magic mushroom tourism industry implies. Yes, Mexico is known for cartels and tequila, mariachi and sombreros. And now magic mushrooms too. Psychedelic tourism is definitely on the rise.

Of all the psychedelics, THC is still the most popular one. For THC users who have a problem with the anxiety or experience paranoia, the alternate delta-8 THC might be preferable. If you think you could benefit from this altered version of THC, take a look at our awesome delta-8 THC deals, and try it out for yourself.

Maria Sabina and Oaxaca mushrooms

Different parts of Mexico are known for different things. Like the town of Tequila, which is the actual birthplace of one of the most popular liquors throughout the world. As it happens, the state of Oaxaca, Mexico is known for its very own thing, as the main point of Mexico’s magic mushroom tourism industry. The Oaxaca highlands area, like San Jose del Pacifico, is specifically known for magic mushrooms and the related tourism, particularly between July and October.

Travelers come to Oaxaca for mushrooms, both from within Mexico, and from all over the world. Magic mushrooms were first discovered in Mexico by Spanish friars, during the time that Mexico was being colonized. Oaxaca mushrooms (or ‘hongos’ in Spanish) were brought into prominence in this area by witch doctor – or Mazatec curandera – Maria Sabina, who used them in her work.

She worked with many rich and powerful people who wanted the benefits of the mushrooms. She became well-known to the public in 1955 when the article ‘Seeking the Magic Mushroom’ written by R Gordon Wasson, the vice-president of JP Morgan, was published. It was this semi-stardom that made her, and her mushrooms, known to Timothy Leary, the Harvard psychologist who went on to become a leading advocate for psychedelics.

Mexican magic mushrooms

Timothy Leary wasn’t the only well-known name to have been inspired by Maria Sabina. In the 1960’s – the era of the hippie, psychedelics were rather big for both individual use, and in celebrity culture. That general area of Oaxaca was visited in this decade by members of the Beatles, the Rolling Stones, Jim Morrison of the Doors, and Bob Dylan, all to take psychedelic mushrooms.

These mushrooms are a big part of local Zapotec culture, and are used for religious and traditional purposes. Law enforcement tends to ignore these uses by indigenous cultures, even though the mushrooms are illegal. In the Zapotec culture, children as young as six-years-old can consume mushrooms as part of their rituals. In fact, the current influx of tourists has done much to disrupt local culture in the area, and has worked to drive a large magic mushroom scam market as well.

Mexico’s magic mushroom tourism industry has brought so many people to Oaxaca, and places like San Jose del Pacifico, and Huautla de Jimenez, where Maria Sabina used to operate from, that tourists getting off the buses in some of these areas can expect to be met by children, waiting to take them to where they can find mushrooms.

What are magic mushrooms? And what are psychedelics?

Magic mushrooms are a grouping of fungi that can grow wild, or be cultivated. Mushrooms with this designation contain psilocybin as a primary psychoactive compound, though many mushrooms contain other psychoactive compounds as well, like Psilocin. Examples of mushrooms in this category include: Psilocybe (the most well-known), Panaeolus, and Conocybe. Mushrooms are often purchased dried out, but can be consumed raw as well. Mushroom trips generally last around six hours.

Both psilocybin and psilocin are hallucinogenic compounds that are both serotonergic, or acting on serotonin receptors in the brain. Magic mushrooms are known for promoting feelings of euphoria, altered mood and perception, distortion in time and reality, heightened feelings of connection between people, intensified feelings of spirituality, and an increased level of introspection.

Psychedelics, the class of drugs that psilocybin and psilocin are known as, is a subset of hallucinogenic drugs, which itself is a subset of psychoactive drugs. Psychedelics are known generally for causing the kinds of effects experienced through magic mushrooms, with altered perception, cognition, and mood, euphoria, spirituality, connectedness, and the rest. Very infrequently are psychedelics associated with unwanted effects and bad trips if dosing is done correctly, but negative effects like increased heart rate, anxiety, sweating, and nausea, are possible.

Mexico's magic mushroom tourism

Recently there has been a renewed interest in psychedelic testing. This is a general continuation of what was started in the mid 1900’s with LSD and psychedelic-assisted therapy, in which the patient is given a psychedelic drug, and then guided through the experience by a professional, who can help the patient use the drug to mentally work out their issues.

Legality of magic mushrooms

Mushrooms are interesting because they fall into a legal loophole in many places of the world. The magic mushroom loophole goes like this: the active psychedelic compounds found in mushrooms, like psilocybin and psilocin, are schedule I drugs according to the Convention on Psychotropic Substances, a UN international drug scheduling treaty meant to police the use, production, and sale of different substances throughout the world. Many countries, like the US, also have drug scheduling laws of their own, and many put these compounds in schedule I of local legislation.

What creates the loophole with magic mushrooms, is that the mushrooms themselves are perfectly legal, and under no global treaty regulation. Under international law, its legal to have the mushrooms, but the compounds inside are illegal. Plus, many places (like Mexico) make designations about how the mushroom is grown, to determine legality.

It’s just like the industrial hemp loophole, which allows industrial hemp to be grown in places where cannabis consumption is illegal, thereby giving residents a way to consume hemp outside of the law. This same loophole also covers products like delta-8 THC, which can be sourced from the *legal THC in hemp plants, thereby creating a compound that is technically illegal according to what it is, but produced completely legally, and not actually mentioned by name in the law.

Putting these drugs in schedule I of drug legislation implies that the compounds are dangerous, addictive, and with no medical benefit. A line like this starts to sound sillier and sillier as it keeps being applied to substances that are so clearly not in that category. And it brings up the question of how we’re supposed to be protected by such laws, and the people who put them in place.

In 2001, this loophole was made all the more clear on a global level, when the (INCB) International Narcotics Control Board (the independent organization that monitors how UN international drug treaties are implemented) secretary of the board, Herbert Schaepe, made the following statement in answer to a question by the Dutch Ministry of Health:

“As a matter of international law, no plants (natural material) containing psilocine and psilocybin are at present controlled under the Convention on Psychotropic Substances of 1971. Consequently, preparations made of these plants are not under international control and, therefore, not subject of the articles of the 1971 Convention.”

Is Mexico’s magic mushroom tourism industry illegal?

Magic Mushrooms Mexico

When it comes to Mexico, the 1984 Ley General de Salud outlaws both psilocybin and psilocin, and even goes farther than the US, specifically mentioning psilocybin-containing fungi as a whole, to be illegal. The law even calls out a few specific species like: Psilocybe Mexicana, and Psilocybe cubensis. Native cultures using mushrooms are not held to enforcement of this law, and wild-growing mushrooms are actually legal!

What is very strange, is that when Mexico signed an amendment to the General Law on Health and the Federal Penal Code in 2009, that both LSD and MDMA were included in the list of drugs that were decriminalized, but magic mushrooms and their compounds, were not. This could, perhaps, be related to the ability for self-cultivation with mushrooms. The idea of decriminalized mushrooms might be a little scarier to big business. After all, once it becomes like cannabis, where personal-cultivation is a regular thing, it will be harder for biotech and pharmaceutical companies to control the industry.

And how likely is a pharmaceutical industry for magic mushrooms? Considering they are already used in tons of places, and that the US’s FDA named magic mushrooms as a ‘breakthrough therapy’ for major depression in 2009, it looks like there certainly will be.

According to the FDA, this “designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies.” This is literally meant to quicken the development of products. If the FDA is pushing this hard for magic mushroom products, it’s a good bet there’s an industry waiting to erupt, and a full legalization might not happen until that time.

Experience Mexico’s magic mushroom tourism industry

If you’re looking to take advantage of Mexico’s magic mushroom tourism, you’ll probably want to head to San Jose Del Pacifico, which is a three hour drive from Oaxaca city, and about 3.5 hours from the Pacific coast. If you simply make it there, you probably won’t have to look too hard, since, as mentioned, the area caters to this tourism. In fact, it’s quite possible that the attendant at your hostel or hotel might ask you if you’re interested. One mushroom trip should cost about $200-250 pesos, but this could vary between locations.

Of course, if you’d rather find them yourself, you can do that too. Just be wary since picking the wrong mushroom could mean a pretty nasty death. If you want to pick them yourself, head to that region between July and October, which is the rainy season. Heading between June and August will likely net the best results.

For those who like things more planned out, there are plenty of magic mushroom retreats like this Buena Vida psilocybin retreat, where participants can take part in a controlled ritual ceremony. Retreats can be found all over the country, as Oaxaca, often considered the capital for magic mushrooms, is not the only location for tourism. Retreats exist in the Mayan Jungle, through Bluaya. Or Life Synergy Retreat which offers retreats in Playa del Carmen, and Tulipanes.

magic mushroom retreat

Conclusion

The general illegality of the compounds within magic mushrooms, and the mushrooms themselves, make the legality of magic mushroom tourism questionable in Mexico. However, it seems to be acceptable for ceremonial use, and when found in the wild. The latter is very important here, because it means if the mushrooms are not being officially cultivated – by you or a company – they’re actually perfectly legal.

In that sense, anyone can legally walk into the woods at any time, and legally pick and use magic mushrooms. Any retreat that incorporates these aspects of the law, can operate perfectly legally. As the general world of psychedelic tourism grows, Mexico is sure to see even more people come through, to trip on its mushrooms.

Hi and welcome to CBDtesters.co, the top spot for all the latest cannabis-related news from around the globe. Check in with us daily so you’re always on top of the ever-changing world of legal marijuana, and sign up to our newsletter so you never miss a thing.

Resources

Delta-8 THC Delivery Methods: Best Way to Get It in You
How to Invest in Multi-Billion Dollar Medical Psychedelics Industry

Are CBD-Infused Beverages The Next Big Thing?
The New Rise of Medical Psychedelics
What is DELTA 8 THC (FAQ: Great resource to learn about DELTA 8THC)

Mexico Delayed Cannabis Bill Again
Delta-8 THC and Athletics – Why the Two Go Together
The CBD Flowers Weekly newsletter (your top resource for all things smokable hemp flowers). Nature’s Magic – The Health Benefits of Psilocybin Mushrooms
Florida Bill Aims to Legalize Medical Magic Mushrooms

The Delta 8 Weekly Newsletter (All you need to know about Delta 8 thc) and the Best Delta 8 THC Deals. Desert Tripping – A Closer Look at Peyote: Spiritual, Medicinal, & Controversial
Kiss the Psychedelic Toads to Treat Mental Illness Delta-8 THC Contaminated Products, or Just Bad Press? Delta 8 Syringes, the Best Vape Ban Workaround
Ayahuasca In the Fight Against Drug Addiction MDMA – The New Way to Treat PTSD
Welcome to the World’s 1st DMT Trials into Depression

Disclaimer: Hi, I’m a researcher and writer. I’m not a medical professional, I have no formal legal education, and I’ve never been to business school. All information in my articles is sourced from other places, which are always referenced, and all opinions stated are mine, and are made clear to be mine. I am not giving anyone advise of any kind, in any capacity. I am more than happy to discuss topics, but should someone have a further question or concern, they should seek guidance from a professional in the relevant field for more information.

The post Mexico’s Magic Mushroom Tourism Industry appeared first on CBD Testers.

Thursday, April 15, 2021 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Thursday, April 15, 2021 | Curated by host Shea Gunther

// Schumer Says It’s Time To End Federal Cannabis Prohibition (Gothamist)

// California Bill To Legalize Possession Of Psychedelics Clears Second Senate Committee (Marijuana Moment)

// Wisconsin Governor ‘Tired’ Of Marijuana Revenue Going To Illinois Next Door (Marijuana Moment)


These headlines are brought to you by Cova Software, the number one dispensary point-of-sale system in North America! Swing over today to see why two thirds of all Canadian cannabis stores run on Cova software, which is also the fastest growing dispensary software in the U.S., with more than a hundred new client dispensaries open for business in January alone!


// Sixth Minnesota House Committee Approves Marijuana Legalization Bill On Its Path To The Floor (Marijuana Moment)

// Swap the crop? New York hemp farmers eager to grow marijuana

// Jushi Buying Dalitso Facility For $22 Million (My Journal Courier (AP)) (Green Market Report)

// Valens Q1 Revenue Increases 25% Sequentially to C$20 Million (New Cannabis Ventures)

// Alabama Medical Marijuana Bill Moves Closer To Floor Vote With House Committee Action (Marijuana Moment)

// Neighbor states give Illinois $10 million in cannabis taxes every month (Leafly)

// With State Law Against Drug Possession Overturned Washington Governor Frees 15 People From Prison (Marijuana Moment)

Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Shutter Ferret/Flickr

Kiss the Psychedelic Toads to Treat Mental Illness

Most people have heard the names LSD, magic mushrooms, and ecstasy before. But not everyone has heard of, say Bufo toads. Yet, even without it being a part of popular culture, or a well-known drug, it is a possible premise for a popular long-running fairy-tale. And perhaps it is this fairytale that helps explain why kissing psychedelic toads, can help treat mental illness.

Medical psychedelics are getting more popular everyday, and the most popular psychedelic drug is still THC! If you’re the kind of person that prefers your THC to be less intense and cause less anxiety, then you’re probably more of a delta-8 THC person. If you haven’t tried this addition to the THC family, check out our awesome delta-8 THC deals to see what it’s all about.

Click HERE to get Delta-8 THC Carts For only $10/CART!

Fairytales are fun

There are different versions of this story around. The most well-known of which was published in 1812 by the Brothers Grimm, called the Frog Prince. In the story, a princess is playing with a golden ball by a spring. When she misses the ball, it falls into the spring and she cannot retrieve it. She is very sad, stating out loud how she would give up everything to get the ball back. A frog hears her and comes over. He tells her he will get her the ball if she will be his friend, which apparently in this context means living with her, sleeping on her pillow, and eating from her plate.

The princess, of course, agrees, but upon receiving her ball back, she runs off with it, ignoring her promise. The frog follows her home, and the princess runs off to consult her father the king, who tells her to respect her promises in life. So she lets the frog in and allows him to eat off her plate, but when he asks to sleep on her pillow, she refuses. When the frog threatens to tell the king that she is refusing, she picks up the frog and throws him against the wall, thus turning him back into a prince and breaking the witch’s spell he was under.

the frog prince

This version seems to be standard, however, in another standard version, the princess kisses the frog in order to change it into the prince. In yet another version, the princess simply allows the frog to be her friend, thereby ending the spell. It’s a kind of trippy story no matter how you look at it. Talking frogs, witch’s spells, and animal/human transformations. Even without considering the possible link between the story, and actual psychedelics, it’s kind of psychedelic anyway.

However, it just so happens, that because a popular version of the story entails the princess kissing the frog in order to break the spell, it brings up a possible tie between the story, and a species of toad that might actually make a person think another person has changed species.

What are psychedelic toads?

Well, for one thing, they’re toads and not frogs, so if there is a tie between the story and the animal, a general mistake was made in categorization. However, it’s the same as confusing a rabbit and a hare, and does little to change the idea of the connection.

In short, psychedelic toads, are toads that contain psychoactive compounds within their skin known as bufotoxins, or a compound called 5-MeO-DMT, that when smoked, or eaten, can cause a psychoactive experience, complete with hallucinations, feelings of connection, euphoria, and so on. Psychedelic drugs are themselves a subset of hallucinogens, which are a class of psychoactive drugs. Psychedelics are known for producing these effects, as well as increasing feelings of spirituality, overall wellbeing, and increasing or distorting perception.

Most well-known psychedelics come from plants like peyote or magic mushrooms, or are made in a lab like LSD. However, the compounds 5-MeO-DMT, and/or bufotoxins like Bufotenin – 5-HO-DMT, can be found in the skin of a living animal. When looking at the chemical structure, you can see that DMT is involved, and in fact, is a related cousin to these compounds, with 5-HO-DMT being 4-6 times stronger than DMT.  

5-HO-DMT is a schedule I compound. So are both MDMA and psilocybin, both of which have been earmarked by the FDA as ‘breakthrough therapies’ for different forms of mental illness. This designation essentially means the drugs are being fast-tracked through medical research trials, so as to get products onto shelves. This implies that scheduling of such compounds will likely change quickly when products are available, and this could include 5-HO-DMT and other psychedelics, as well.

psychedelic toads

There are several different species of toads that have these compounds, with the most well-known species being the Incilius alvarius, or Bufo alvarius (Colorado River Toad/Sonoran Desert Toad). Usage of toads in this way dates back to the Olmec period in pre-Columbian Mesoamerica, from around 1,200 BCE to approximately 400 BCE.

5-MeO-DMT, or 5-Methoxy- N,N-dimethyltryptamine, is a compound found in different plants, as well as the Bufo variety of toads. It has been used since ancient times, and it more recent scientific investigation it was found that it can assist with spiritual exploration, that it’s not addictive, and that it might be good psychotherapeutically. Effects of 5-MeO-DMT can be felt within a second of inhalation, and trips last anywhere from as short as seven minutes, to as long as 90 minutes.

Psychedelic toads and mental illness

If you thought psychedelic toads weren’t studied for mental illness, you’d be mistaken. In 2018, a study came out about the unintended anxiety-reducing and depression-reducing effects of 5-MeO-DMT. The study examined people using the drug for spiritual or recreational reasons, and found self-reported improvements on both fronts. Respondents completed an anonymous survey, which found that 80% of those who responded who had been diagnosed with depression, felt improvement, and 79% of respondents who had been diagnosed with anxiety, also saw improvement in how they felt. Few felt unchanged, and a small amount felt worse than before by a very small margin.

In another study from 2019 about psychedelic toads and mental illness, the effects of inhaling 5-MeO-DMT vapor on affect and cognition, were measured. 5-MeO-DMT comes from the parotoid glands of the Bufo alvarius toad. The goal of the study was to investigate the semi-immediate and long-term effects of inhaling this secretion. The study participants were measured before the inhalation to establish a baseline measurement, within 24 hours of it, and again a month later. Trials were conducted in different parts of Europe, and participants were given just a single inhalation of the secretion.

medical psychedelics

The results of the study showed an increase in life satisfaction ratings and convergent thinking within 24 hours after inhalation, and was maintained a full month later. Mindfulness ratings actually went up over time, and at four weeks reached a statistically significant level. Depression, anxiety, and stress ratings all went down immediately after inhalation, and also reached a statistically significant level at four weeks. Those who experienced ego dissolution or ‘oceanic boundlessness’ – a measure of the spirituality aspect experienced, reported higher levels of satisfaction, and lower levels of depression, stress, and anxiety.

In a comparison study concerning spiritual intensity, between 5-MeO-DMT and psilocybin – the psychoactive compound in magic mushrooms, it was found that the two substances produce spiritual experiences that are comparable. 5-MeO-DMT was administered to 20 participants who received 50 mg vaporized of the compound. The results of this were compared to a previously conducted psilocybin study, where participants received 30 mg of that compound, and the general spiritual intensity was found to be the same.

Issues

The main issue with extracting a drug from an actual living being, is that you generally kill, or harm, that actual living being. For the same reason its often frowned on for elephants to be killed for their tusks, the same can be said for indigenous toad populations, which have been affected by their capture and use as a psychedelic drug. This is one place in life where a synthetic answer is most definitely preferable to the killing of a whole species.

Conclusion

As research into different psychedelic compounds continues, psychedelic toads will likely come to the forefront of mental illness treatment, especially synthetic versions. Given the shorter duration time (much like DMT), and the reported positive benefits, something as strange to think of as a psychedelic toad, might actually be one of the best weapons against anxiety, depression, and other forms of mental illness.

Hello! Thanks for stopping by CBDtesters.co, your best spot for the most current cannabis-related news from all around the world. Join us regularly so you’re always on top of the exciting world of legal cannabis, and sign up to our newsletter so you never miss a story.

Resources

How to Invest in Multi-Billion Dollar Medical Psychedelics Industry
The New Rise of Medical Psychedelics

Welcome to the World’s 1st DMT Trials into Depression
Germany Leads EU in Cannabis Oil Imports…and Exports
What is DELTA 8 THC (FAQ: Great resource to learn about DELTA 8THC)

Florida Bill Aims to Legalize Medical Magic Mushrooms
Desert Tripping – A Closer Look at Peyote: Spiritual, Medicinal, & Controversial
The CBD Flowers Weekly newsletter (your top resource for all things smokable hemp flowers). German Cannabis Flower Market is Ready to Explode
Psychedelic-Assisted Therapy, and How It Works

The Delta 8 Weekly Newsletter (All you need to know about Delta 8 thc) and the Best Delta 8 THC Deals. Can LSD Treat Your Mental Illness?
DIY: How to Make Delta-8 THC at Home MDMA – The New Way to Treat PTSD Delta-8 THC and the UK: Is It Legal?
Ayahuasca In the Fight Against Drug Addiction German Medical Cannabis – A Model For Europe, As Prices Fall
Delta 8 Syringes – Why are they important?

Disclaimer: Hi, I’m a researcher and writer. I’m not a medical professional, I have no formal legal education, and I’ve never been to business school. All information in my articles is sourced from other places, which are always referenced, and all opinions stated are mine, and are made clear to be mine. I am not giving anyone advise of any kind, in any capacity. I am more than happy to discuss topics, but should someone have a further question or concern, they should seek guidance from a professional in the relevant field for more information.

The post Kiss the Psychedelic Toads to Treat Mental Illness appeared first on CBD Testers.

4 weed products journalist Madison Margolin can’t live without

Madison Margolin is the co-founder and managing editor of DoubleBlind, the biannual print magazine and digital media outfit that’s taking the psychedelics movement by storm. Before starting the magazine, she and co-founder Shelby Hartman were both prolific cannabis journalists. Though many will be most familiar with Margolin’s cannabis coverage in a wide range of publications over the last five years, she’s been covering the political, cultural, and spiritual impact of psychedelics since her college days. 

While still in journalism school at Columbia University, Margolin was reporting on the Orthodox Jewish community in New York and met a bunch of kids from orthodox backgrounds who were experimenting with psychedelics, “exploring their relationship to religion and spirituality through these alternative drug experiences,” Margolin told Weedmaps, “I got really curious about that and started writing almost immediately about the relationship between Judaism and psychedelics. That was like five years ago before I even had my job at the Village Voice.” 

Margolin started covering New York’s cannabis policy rollout for the Voice in 2015. At the same time, she had spent several months working on a story about the Empire State’s burgeoning psychedelic scene, where she was, “looking at the research that was coming out of NYU.” She also became familiar with the newly opened Alchemist Kitchen, a community space offering talks on psychedelics and with room to sell goods and tinctures.

The Voice was sold in October 2015, just as Margolin’s psychedelics coverage was about to be a cover story. “They got a new editor who basically was like, ‘Your drug coverage is cliché. The Village Voice is over drugs,’ and he killed my psychedelics story.” That same editor also killed her weed column, so Margolin would go on to cover the cannabis beat for Rolling Stone, Playboy, High Times, Nylon, Bon Appetit, Broccoli, LA Weekly, VICE, and a host of other major magazines and digital outlets. 

For Margolin, the modern cannabis and psychedelics movements are connected by the psychoactive experience and how it can affect all other aspects of life — science, policy, culture, history, medicine, mental health, spirituality, etc. “When writing about any drug, whether it’s cannabis or psychedelics or even heroin and opiates and whatever, it’s a way to talk about other things in society,” Margolin said while reflecting on all the places and communities her cannabis coverage has taken her for the past five years. One particular day in Jerusalem stood out to her as a poignant example where all these ideas intersected in a special way.  

The day started with an interview with Raphael Mechoulam, the legendary Israeli scientist who pioneered the isolation of THC and the discovery of endocannabinoids. “I did this whole story on the cannabis scene in Israel-Palestine for Tablet, a Jewish magazine,  so I spoke to Mechoulam, which was really special. Then I went to East Jerusalem, which is more the Palastinian side of the city, with a translator. It was kind of interesting man-on-the-street reporting. I think it was interesting to be in this place where trauma is so ubiquitous on all sides of the equation. Cannabis is such an obvious choice to treat trauma, and to experience that first hand with Israelis and Palestinians — and to talk to the guy who was so instrumental [in cannabis science and medicine] — was really powerful.”

The transition from full-time cannabis reporting to running her own psychedelics magazine began in 2018, when fellow-reporter Shelby Hartman reached out to her about the project. “Shelby and I had both gone to Columbia for journalism school, and then we were sort of doing similar things in the field afterward. And Shelby had this idea when she was meditating to do a psychedelics magazine, sort of inspired by Broccoli, a really beautiful magazine that covered psychedelics but also merged high-end design with investigative-heavy reporting.” 

Margolin signed onto the idea right away. “We both had full-time jobs at the time. I was at Civilized and [Shelby] was at Herb, and we didn’t really know where it would go. We were just like, ‘this seems like a cool side project to do,’ and then it kind of snowballed into what it is right now.”

Margolin and Hartman now lead a publication that, in their own words, speaks to “everyone who is curious about psychedelics. And we are speaking to anyone craving fresh perspectives on some of the most important issues of our time […] and the aching that people around the globe feel for spirituality or some other collective sense of meaning.” 

For Margolin and for DoubleBlind, shedding light on the grassroots nature of the psychedelics and cannabis movements is paramount.

“People are like, ‘oh yeah, cannabis is like a big industry these days.’ And it’s kind of obnoxious because it’s built on the backs of people who have been going to jail for decades, and risking their freedoms and putting their families at risk. That’s something I hope that, as people read about this [industry] stuff in Forbes, they recognize that it’s built on people who are not being featured in Forbes.”

Margolin continued, “I just don’t think people recognize the tension between the industry and the movement, the movement being something that’s really grassroots and we’re dealing with organic matter, and there’s indigenous wisdom behind it and decades of folk wisdom and street wisdom, and that is the culture.”

Here are four weed products Madison Margolin can’t live without.

Prismatic Plants Good Day and Good Night CBD Tinctures

Prismatic Plants offers daytime and nighttime CBD tincture formulas, both designed to have an appropriate calming effect. Margolin uses both. 

“I have scoliosis and my back can get kinky, and sometimes it can hurt. But it actually hasn’t been like that in a long time, and I don’t know if it’s cause I take CBD, but I think that might have to do with inflammation. I also use it for anxiety. Sometimes if I’m tripping, I like to have CBD on hand, basically if I’m feeling anxious.”

Papa & Barkley 1:3 THC Releaf Balm 

Papa & Barkley‘s THC-rich Releaf Balm is a whole-plant-infused salve that Margolin has used for pain relief. “I’ve also had tendonitis,” a condition most writers are at least somewhat familiar with, “so I’ve used that and rubbed it in my wrist.” 

Dad Grass CBD Pre-rolls

As CBD pre-rolls become a major staple of the cannabis market, it’s important to know where the quality is. Margolin doesn’t smoke weed as much as she used to, and tends to prefer CBD-heavy joints when she does. Dad Grass hemp pre-rolls “serve up a clean buzz without the fuss,” and are tailored to “revive the casual smoke.” 

Moon Made Farms Flower

Moon Made Farms is owned and operated by former producer, musician, event promoter, and documentary filmmaker, Tina Gordon, who relocated to Southern Humboldt County in 2007 to grow and advocate for cannabis. 

“I try to opt for outdoor, sungrown, small-batch farms.” Margolin told Weedmaps, “Moon Made Farms is a good one. Tina actually tracks the moon cycle to see how the moon affects the plants.”

Interview by Nic Juarez. Written by Andy Andersen. Photo courtesy of Zoe Wilder. Graphic by David Lozada/Weedmaps

The post 4 weed products journalist Madison Margolin can’t live without appeared first on Weedmaps News.

How to Invest in Multi-Billion Dollar Medical Psychedelics Industry

As the legal cannabis market booms, another class of drugs on the horizon is getting closer to legalization, with its own impending boom coming. And that means a whole new place for investment. So as MDMA, psilocybin, and DMT work their way through medical trials, here’s how to invest in this new medical psychedelics field.

Looking to learn more about Medical Psychedelics?
Subscribe to the Medical Cannabis Weekly Newsletter!

What are psychedelics?

Psychedelics are a subset of hallucinogenic drugs, which themselves are a subset of psychoactive drugs. Whether made in a lab like LSD, or found in nature like psilocybin or peyote, psychedelics are known for causing ‘trips’. When a person is tripping, they may have altered perceptions of the world around, experience/feel/taste/see/hear things that are not real (hallucinations), feel a heightened sense of connection to those around them, experience euphoria, feel a sense of spirituality and connectedness with the universe, and a greater sense of self-introspection. A large percentage of psychedelics are serotonergic, meaning they effect serotonin receptors in the brain, though they can do this in different ways.

Some drugs like DMT produce short trips of less than an hour in duration. While other drugs like LSD, psilocybin, and mescaline can cause trips that last for many hours, as many as eight or ten. Sometimes people experience bad trips in which negative, or even scary, hallucinations are experienced, and/or a rapid heartbeat, sweating, nausea, disorientation, and fatigue occur. There is indication that the majority of these symptoms can be controlled through proper dosing. In fact, many therapeutic psychedelic users consume the drugs in micro-doses.

All psychedelics are Schedule I in the Convention on Psychotropic Substances, a drug scheduling treaty which defines the legality of different compounds globally. Starting with the Staggers-Dodd bill in 1968 which illegalized LSD and psilocybin, and finishing with the placement in the Convention, making all such substances illegal to buy, sell, or consume, with no purported medical value.

psychedelics

Psychedelics have been used for thousands of years, all throughout the world, though their uses in medicine in the mid-1900’s, and proposed uses today, are generally different than the shamanistic/ritualistic way they were primarily used in history, although this is not to say that there were not traditions that did use psychedelics therapeutically. Technically, if a shaman is consuming ayahuasca to get rid of demons, I suppose that could be thought of as therapeutic anyway.

Medical psychedelics research

Psychedelics, particularly, LSD, were introduced to modern medicine around the 1950’s after Albert Hoffman synthesized the compound in Switzerland in 1938. Several psychotherapists at the time, like Humphry Osmond and Ronald Sandison caught onto the idea, bringing these treatments to England and America. Hoffman conducted, among other research and therapy, the Saskatchewan trials, and ultimately came up with the idea of ‘psychedelic therapy’ in which a single large dose of LSD was given along with therapy sessions.

‘Psycholytic therapy’ is what Ronald Sandison’s version became known as in the UK, with the difference being that Sandison’s treatment style was to do multiple sessions with smaller amounts of the drug that increased through the process. Both doctors found great success particularly with alcohol addiction. How much success? According to the Saskatchewan trials, as many as 40-45% of drinkers were still not drinking a full year after the therapy session.

Unfortunately, when the drugs were made illegal, all ability to continue such treatments ended, and the ability for research into the field was completely stymied, and did not pick up again until much more recently. However, to give an idea of the massive turnaround that has been going on when it comes to psychedelics, consider that the US’s Food & Drug Administration (FDA), singled out both psylocibin in 2019 and MDMA in 2017 as ‘breakthrough therapies’ for depression and PTSD respectively. Such a designation by the FDA is meant to speed up research and development for products deemed necessary for health.

This indicates a desire by a US government agency to not only test these drugs, but to get them to market. And they’re all schedule I right now. One exception to psychedelics all being schedule I, however, is magic mushrooms. Though its psychoactive components like psilocybin are Schedule I, and therefore illegal, the plants themselves are not outlawed, creating a bit of gray area in terms of mushroom use, cultivation, and production. This gray area could prove useful in the future.

What can be expected?

If you’re wondering why this matters, consider how massive – and growing – the legal cannabis markets are. Well, psychedelics offer many of the same medical benefits, especially psychologically, with possibly added abilities in other departments. And they’ve proven to be very safe. As an industry in which much of it is pharmaceutical to begin with, it’s a safe bet that these drugs are going to pick up quickly. Because the pharma world is sure to take a massive interest, it gives even more reason to invest in medical psychedelics now, before everything explodes.

psychedelic-assisted therapy

So how much is it worth? I’m not the kind of writer who generally likes to get into these numbers. Every publication makes its own predictions, off its own information, and very rarely do these predictions seem to consider world changes. Whatever the size of the CBD industry was originally predicted to grow to a few years ago, that number would be invalid by now because it didn’t account for THC-based medicines growing in popularity, or legal markets, or psychedelics.

Imagine how much psychedelics could eat away at cannabis revenue. And not only that, any predictions of the future market size for psychedelics would have to take into account the still expanding cannabis markets (with more countries constantly legalizing in some form or another), and the question mark of what currently unforeseen factors could upend the trend a few years down the line. So, I’m not concerned with too many predictor numbers, but here’s just one, in order to get an idea what we’re dealing with.

PRNewswire, citing an analysis by Data Bridge Market Research, explained the forecast for 2020-2027, in which the field is expected to grow to $6.8 billion by 2027. It was worth just over $2 billion in 2019.

Best ways to invest in growing medical psychedelics field

Now that a certain barrier seems to be broken, more companies are conducting clinical trials, getting patents, and starting to get clearances for products. In fact, if you thought the psychedelics market was off limits, you’d be very much mistaken. Not only is this a growing market with a lot of possibility, but companies are already staking their claim, leaving room for you to start investing. So, if you like the idea of getting in on something before it explodes, consider investigating the following companies, and invest in the medical psychedelics field.

Much like with cannabis, Canada is quickly establishing itself as a leader in medical psychedelics, with the top companies coming out of this country. In the first half of 2020, $150 million USD was raised by six different companies: Mind Medicine, COMPASS Pathways, Field Trip Psychedelics, ATAI Life Sciences, Orthogonol Thinker, and Numinous Wellness. Mindmed and Numinous are already publicly listed companies. This is an early stage entry for investors. In fact, to give an idea of how seriously Canada is taking this, the first exchange traded fund – The Horizons Psychedelic Stock Index ETF, made its debut in January. ETF’s are like regular asset exchanges, except that they include a mix of stocks, commodities, and bonds. This exchange is solely for psychedelics.

The CEO of the fund, Steve Hawkins, said that while larger pharmaceutical companies have been admitted to the fund, the idea is to keep it mainly for smaller psychedelics companies. Companies can be added to the fund if they can tick the following boxes: be a part of a regular US or Canada-based stock exchange, be a biotechnology company focusing on medical psychedelic research, be a producer and/or supplier of psychedelic medicines, and be a company that works within the general supply chain for psychedelic medications.

medical psychedelics

Biggest names so far

When it comes to emerging fields and investing, the majority of people will never get there preemptively, and will instead act by reaction. For anyone who wants to get in on it before the top blows off, the following companies currently provide the best prospect for future growth, expansion, approval, and ability for revenue. These names should be noted, they will likely be bringing you the first approved medical psychedelic products, and for anyone looking to invest in this rapidly growing field of medical psychedelics, they stand out as the best options so far.

Mind Medicine is one of the furthest along when it comes to getting a product out there. It’s a pharmaceutical company that specifically works to develop psychedelic medications. The company is currently in the middle of six different trials on drugs like MDMA, LSD and DMT. In January of 2021, MindMed announced the first ever clinical trials to involve a combination of MDMA and LSD, with company president Dr. Miri Halperin Wernli stating:

“I believe that when LSD and MDMA are taken together they have exceptional potential to open a window into our mind which will awaken it to new levels of awareness by changing the fluidity of the ‌state‌ ‌of‌ ‌consciousness, amplifying‌ ‌changed‌ ‌perceptions,‌ ‌intensifying ‌emotions‌, ‌and‌ stimulating ‌novel‌ ‌thoughts. It is like a gateway to a multidimensional universe.”

When it comes to MDMA trials, MAPS – Multidisciplinary Association for Psychedelic Studies,  is also making its way to approval. MAPS entered phase III of its trials into MDMA for PTSD, and aligned this phase with the FDA according to a Special Protocol Assessment made directly with the FDA. This means that so long as the trials show clinically significant results, the study will already check all FDA regulatory boxes, and make it that much easier for approval.

However, a psychedelic drug has technically already been approved by the FDA. In March of 2019, Johnson & Johnson’s Spravato got approval. The spray treatment is considered for those who have not received a benefit from at least two separate anti-depressants. Spravato is a drug that’s a chemical cousin of the drug ketamine, which is classified as a dissociative drug, but also as a psychedelic. The medication is meant for severe depression.

There are tons of companies popping up. Apart from the companies already listed, prospective investors should check out Champignon Brands, Hollister Biosciences, Better Plant Sciences, Captiva Verde Land, Core One Labs, Cybin, Empower Clinics, Ehave, Jazz pharmaceuticals and EGF Theramed Health. All of these companies are associated in some way or other with the production of psychedelic medications. And while I have yet to see it mentioned in an article, it seems to me that what might upend everything I just said, is the ability to cultivate magic mushrooms.

LSD

Something to consider

Much like cannabis, mushrooms come with the ability for easy self-cultivation, as well as large scale cultivation. People who invest in today’s cannabis cultivation already know the value of having growing fields. Imagine the same thing, but with mushrooms. I personally believe that the biggest way in the future to invest in medical psychedelics, will be through the growing of mushrooms.

As stated, this is my opinion, and has not been discussed much as far as I can tell. This is not shocking though, and really doesn’t mean much, as this topic is also an undesirable one for any biotech or pharmaceutical company that – much like with cannabis – would much prefer you know nothing about how to do this on your own. And much like cannabis, it’s easy enough to learn how for anyone who needs some help getting started. Plus, since cultivation and sale of the mushrooms themselves is actually legal in many places, it’s way more legal to grow a field of mushrooms in much of the world, than to grow a field of cannabis.

How to invest in Medical Psychedelics – Conclusion

That the medical psychedelics field is coming is not as much up for debate as many would believe. It might be growing in the shadow of the cannabis market, and being kept quiet until the ability for large scale monetization is possible, but it’s coming, and it will be big. For those who want to invest in the growing medical psychedelics field, getting in now is probably the best idea, and with all the new companies popping up every day, it’s sure to become a heated race very soon.

Hello and welcome to CBDtesters.co, the best location to get up-to-date cannabis-related news from around the globe. Join us frequently to stay in-the-loop on the exciting world of legal cannabis, and sign up for our newsletter so you always know what’s going on.

References

Why the Vape Ban Is Happening, and How It Will Impact Delta-8 THC
Florida Bill Aims to Legalize Medical Magic Mushrooms

DIY: How to Make Delta-8 THC at Home
Here is everything wrong with Biden’s “forced rehab” plan for drug reform
What is DELTA 8 THC (FAQ: Great resource to learn about DELTA 8THC)

Can LSD Treat Your Mental Illness?
Welcome to the World’s 1st DMT Trials into Depression
The CBD Flowers Weekly newsletter (your top resource for all things smokable hemp flowers). Delta 8 / 9 / 10 / 11… How Many THCs Are Out There?
The New Rise of Medical Psychedelics

The Delta 8 Weekly Newsletter (All you need to know about Delta 8 thc) and the Best Delta 8 THC Deals. How To Choose Delta-8 THC Flowers?
Ayahuasca In the Fight Against Drug Addiction The Many Faces of Tetrahydrocannabinol – Different Types of THC and Their Benefits Psychedelic-Assisted Therapy, and How It Works
Desert Tripping – A Closer Look at Peyote: Spiritual, Medicinal, & Controversial Nature’s Magic – The Health Benefits of Psilocybin Mushrooms

Disclaimer: Hi, I’m a researcher and writer. I’m not a medical professional, I have no formal legal education, and I’ve never been to business school. All information in my articles is sourced from other places, which are always referenced, and all opinions stated are mine, and are made clear to be mine. I am not giving anyone advise of any kind, in any capacity. I am more than happy to discuss topics, but should someone have a further question or concern, they should seek guidance from a professional in the relevant field for more information.

Yup, there’s a vape ban in the USA, but that doesn’t mean we can’t get you any delta-8 THC products at all. Delta-8 THC is the less psychoactive THC compound that produces less anxiety and panic for users. Check out the great delta-8 THC deals we’ve got, and start experiencing delta-8 in a whole new way.

The post How to Invest in Multi-Billion Dollar Medical Psychedelics Industry appeared first on CBD Testers.

Wednesday, March 24, 2021 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Wednesday, March 24, 2021 | Curated by host Shea Gunther

// Marijuana Banking Bill Reintroduced In Senate With Nearly A Third Of The Chamber Signed On (Marijuana Moment)

// Texas Cops Just Arrested and Killed a Man for Possessing One Joint Worth of Weed (Merry Jane)

// Colorado Governor Signs Marijuana Social Equity Bill As Lawmakers Vote To Increase Possession Limit (Marijuana Moment)


These headlines are brought to you by Cova Software, the number one dispensary point-of-sale system in North America! Swing over today to see why two thirds of all Canadian cannabis stores run on Cova software, which is also the fastest growing dispensary software in the U.S., with more than a hundred new client dispensaries open for business in January alone!


// New York Lawmakers Overcome Marijuana Legalization ‘Impasse’ And Expect Bill In ‘Next Day Or So’ (Marijuana Moment)

// South Dakota Governor Floats Marijuana Decriminalization As Part Of Medical Cannabis Compromise (Marijuana Moment)

// Trulieve Q4 Revenue Increases 24% Sequentially to $168 Million (New Cannabis Ventures)

// TerrAscend Q4 Revenue Increases 28% Sequentially to C$65 Million (New Cannabis Ventures)

// Ayr Wellness Completes $75 Million Arizona Acquisition (New Cannabis Ventures)

// Maine medical marijuana caregivers ‘greatly disturbed’ by proposed industry rules (Bangor Daily News)

// Maryland adult-use marijuana legalization effort fails for this year (Marijuana Business Daily)

Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Sebastian Vital/Flickr

Tuesday March 23, 2021 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, March 23, 2021 | Curated by host Shea Gunther

// New Mexico Governor Plans Special Session On Marijuana As Legalization Bill Stalls On Final Stretch (Marijuana Moment)

// Same old Joe: Rebuffing staff who smoked pot fits Biden’s MO (Politico)

// North Dakota Senators Advance House-Passed Marijuana Legalization Bill (Marijuana Moment)


These headlines are brought to you by Agilent, a Fortune 500 company known for providing top-notch testing solutions to cannabis and hemp testing labs worldwide. Are you considering testing your cannabis in-house for potency? Agilent is giving away a FREE 1260 HPLC system for one year! If you are a Cultivator, processor, or cannabis testing lab you may qualify for this giveaway. Open up bitly.com/cannabis-contest to answer a few quick questions to enter to win!


// Cuomo Caves On Marijuana Homegrow And Equity Funding, Top New York Senator Signals (Marijuana Moment)

// Rhode Island Governor Supports Marijuana Expungements Despite Excluding Policy From His Legalization Plan (Marijuana Moment)

// West Virginia licenses medical cannabis testing lab (Marijuana Business Daily)

// Akerna Announces Financial Results for the Quarter Ended December 31, 2020 (Cision PR Newswire)

// Andrew Yang Urges Legalization Of Psilocybin And Marijuana At New York City Mayoral Forum (Marijuana Moment)

// New Jersey Governor ‘Open-Minded’ On Decriminalizing All Drugs (Marijuana Moment)

// As PA ponders legalizing pot, some 20200 possession arrests were made last year (Bucks County Courier Times)

Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Third Way Think Tank/Flickr

Wednesday March 17, 2021 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, March 16, 2021 | Curated by host Shea Gunther

// Connecticut House Speaker Says ‘Optimism Abounds’ As Marijuana Legalization Negotiations Proceed (Marijuana Moment)

// Legalizing Marijuana Has Been A ‘Uniformly Positive’ Move In Washington State Governor Says (Marijuana Moment)

// Oregon Governor Appoints Panel To Implement Historic Legal Psilocybin Therapy Measure (Marijuana Moment)


These headlines are brought to you by Agilent, a Fortune 500 company known for providing top-notch testing solutions to cannabis and hemp testing labs worldwide. Are you considering testing your cannabis in-house for potency? Agilent is giving away a FREE 1260 HPLC system for one year! If you are a Cultivator, processor, or cannabis testing lab you may qualify for this giveaway. Open up bitly.com/cannabis-contest to answer a few quick questions to enter to win!


// California awards $15 million more in cannabis social equity grants (Marijuana Business Daily)

// Ann Arbor to put $476K in new marijuana revenue to social equity programs (Michigan Live)

// Majority Of Florida Voters Back Marijuana Legalization And Oppose THC Limits, New Poll Finds (Marijuana Moment)

// Columbia Care Beats On Revenue, Misses On Earnings (Green Market Report)

// Village Farms Cannabis Sales Grow 2% Sequentially to $17.3 Million in Q4 (New Cannabis Ventures)

// It’s completely legal, but still the hemp industry has trouble finding banks – here’s why (Columbus Dispatch)

// State’s first on-site consumption cannabis bar set to open (KFVS 12 CBS)

Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Dannel Malloy/Flickr

Tuesday, March 16, 2021 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, March 16, 2021 | Curated by host Shea Gunther

// Arizona adult-use cannabis sales hit $2.9 million during initial 10 days (Marijuana Business Daily)

// New York Inches Closer To Legalization (Green Market Report)

// D.C. Psychedelics Decriminalization Initiative Officially Takes Effect (Marijuana Moment)


These headlines are brought to you by Agilent, a Fortune 500 company known for providing top-notch testing solutions to cannabis and hemp testing labs worldwide. Are you considering testing your cannabis in-house for potency? Agilent is giving away a FREE 1260 HPLC system for one year! If you are a Cultivator, processor, or cannabis testing lab you may qualify for this giveaway. Open up bitly.com/cannabis-contest to answer a few quick questions to enter to win!


// Dozens of adult-use cannabis shops coming soon to Portland (Portland Press Herald)

// Greenrose SPAC Buys Four Properties In $210 Million Move (Green Market Report)

// Vermont Would Decriminalize Drugs Under New Bill (Marijuana Moment)

// Cannabis Technology Platform dutchie Raises $200 Million and Acquires Greenbits and Leaf Logix (New Cannabis Ventures)

// Sundial to Contribute $100 Million to Cannabis Investment Joint Venture (New Cannabis Ventures)

// Senators deadlock over cannabis legalization as session nears end (Albuquerque Journal (AP))

// North Dakota Marijuana Legalization Bill Receives First Senate Committee Hearing Following House Passage (Marijuana Moment)

Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Dorian Wallender/Flickr